A Series of Function Blocking Antibodies against the αvβ3 Integrin Bind Allosteric to the Ligand Binding Site and Induce Ligand Dissociation

References

• Barbas C. F., Languino L., Smith J. W. High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site. Proc. Natl. Acad. Sci. USA 1993; 90: 10003–10007
   PubMed Web of Science ®Google Scholar
• Berditchevski F., Tolias K. F., Wong K., Carpenter C. L., Hemler M. E. A novel link between integrins, transmembrane-4 superfamily proteins (CD63 and CD81), and phosphatidylinositol 4-kinase. J. Biol. Chem 1997; 272: 2595–2598
   PubMed Web of Science ®Google Scholar
• Brooks P. C., Clark R. A., Cheresh D. A. Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994; 264: 569–571
   PubMed Web of Science ®Google Scholar
• Cheresh D. A., Spiro R. C. Biosynthetic and functional properties of an Arg-Gly-Asp directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand Factor. J. Biol. Chem 1987; 262: 17703–17711
   PubMed Web of Science ®Google Scholar
• Choi E. T., Engel L., Callow A. D., Sun S., Trachtenberg J., Santoro S., Ryan U. S. Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA. J. Vase. Surg 1994; 19: 125–134
   PubMed Web of Science ®Google Scholar
• Coller B. S. Platelet GPIIb/IIIa antagonists: the first antiintegrin receptor therapeutics. J. Clin. Invest 1997; 99: 1467–1471
   PubMed Web of Science ®Google Scholar
• Coller B. S., Anderson K., Weisman H. F. New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb. Haemost 1995; 74: 302–308
   PubMed Web of Science ®Google Scholar
• de St. Groth S. F., Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J. Immunol. Methods 1980; 35: 1–21
   PubMed Web of Science ®Google Scholar
• Engleman V. W., Nickols G. A., Ross P. F., Horton M. A., Griggs D. W., Settle S. L., Ruminski P. G., Teitelbaum S. L. A peptidomimetic antagonist of the αvβ3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J. Clin, Invest 1997; 99: 2059–2061
   PubMed Web of Science ®Google Scholar
• Genetta T. B., Mauro V. F. ABCIXIMAB: a new antiaggregant used in angioplasty. Ann. Pharmacother 1996; 30: 251–257
   PubMed Web of Science ®Google Scholar
• Hemler M. E., Mannion B. A., Berditchevski F. Association of TM4SF proteins with integrins: relevance to cancer. Biochim. Biophvs. Ada 1996; 1287: 67–71
   PubMed Web of Science ®Google Scholar
• Horton M. A., Dorey E. L., Nesbitt S. A., Samanen J., Ali F. E., Stadel J. M., Nichols A., Greig R., Helfrich M. H. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis. J. Bone. Miner. Res 1993; 8: 239–247
   PubMed Web of Science ®Google Scholar
• Hu D. D., Barbas C. F.I., Smith J. W. An allosteric Ca2+ binding site on the β3-integrins that regulates the dissociation rate for RGD ligands. J. Biol. Chem 1996; 271: 21745–21751
   PubMed Web of Science ®Google Scholar
• Hu D. D., Lin E. C.K., Kovach N. L., Hoyer J. R., Smith J. W. A biochemical characterization of the binding of osteopontin to integrins αvβ1 and αvβ5. J. Biol. Chem 1995; 270: 26232–26238
   PubMed Web of Science ®Google Scholar
• Hynes R. O. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992; 69: 11–25
   PubMed Web of Science ®Google Scholar
• Leavesley D. I., Ferguson G. D., Wayner E. A., Cheresh D. A. Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J. Cell Biol 1992; 117: 1101–1107
   PubMed Web of Science ®Google Scholar
• Liaw L., Lindner V., Schwartz S. M., Chambers A. F., Giachelli C. M. Osteopontin and β3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circulation Res 1995; 77: 665–672
   PubMed Web of Science ®Google Scholar
• Liaw L., Lombardi D. M., Almeida M. M., Schwartz S. M., deBlois D., Giachelli C. M. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioseler. Thromb. Masc. Biol 1997; 17: 188–193
   PubMed Web of Science ®Google Scholar
• Lin E. C.K., Ratnikov B. I., Tsai P. M., Carron C. P., Myers D. M., Barbas C. F.I., Smith J. W. Identification of a region in the integrin β3 subunit that confers ligand binding specificity. J. Biol. Chem 1997a; 272: 23912–23920
   PubMed Web of Science ®Google Scholar
• Lin E. C.K., Ratnikov B. I., Tsai P. M., Gonzalez R., McDonald S., Pelletier A. J., Smith J. W. Evidence that the integrin β3 and β5 subunits contain a metal ion-dependent adhesion site-like motif but lack an I domain. J. Biol. Chem 1997b; 272: 14236–14243
   PubMed Web of Science ®Google Scholar
• Lindberg F. P., Gresham H. D., Schwarz E., Brown E. J. Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in αvβ3-dependent ligand binding. J. Cell Biol 1993; 123: 485–496
   PubMed Web of Science ®Google Scholar
• Pijuan-Thompson V., Gladson C. L. Ligation of integrin αβ1 is required for internalization of vitronectin by integrin αvβ3. J. Biol. Chem 1997; 272: 2736–2743
   PubMed Web of Science ®Google Scholar
• Pratner C. A., Plotkin J., Jaye D., Frazier W. A. The Properdin-like type I repeats of human thrombospondin contain a cell attachment site. J. Cell Biol 1991; 112: 1031–1040
   PubMed Web of Science ®Google Scholar
• Price J. E., Polyzos A., Zhang R. D., Daniels L. M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50: 717–721
   PubMed Web of Science ®Google Scholar
• Ruoslahti E. RGD and other recognition sequences for integrins. Ann. Rev. Cell Dev. Biol 1996; 12: 697–715
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attraction of proteins for small molecules and ions. Ann. N Y Acad. Sci 1949; 51: 660–672
   Web of Science ®Google Scholar
• Schwartz M. A., Brown E. J., Fazeli B. A 50-kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. J. Biol. Chem 1993; 268: 19931–19934
   PubMed Web of Science ®Google Scholar
• Smith J. W., Hu D., Satterthwait A., Pinz-Sweeny S., Barbas C. F.I. Building synthetic antibodies as adhesive ligands for integrins. J. Biol. Chem 1994a; 269: 32788–32795
   PubMed Web of Science ®Google Scholar
• Smith J. W., Piotrowicz R. S., Mathis D. M. A mechanism for divalent cation regulation of β3-integrins. J. Biol. Chem 1994b; 269: 960–967
   PubMed Web of Science ®Google Scholar
• Takada Y., Puzon W. Identification of a regulatory region of integrin β1 subunit using activating and inhibiting antibodies. J. Biol. Chem 1993; 268: 17597–17601
   PubMed Web of Science ®Google Scholar
• Takagi J., Kamata T., Meredith J., Puzon-McLaughlin W., Takada Y. Changing ligand specificities of αvβ3 and αvβ1 integrins by swapping a short diverse sequence of the β subunit. J. Biol. Chem 1997; 272: 19794–19800
   PubMed Web of Science ®Google Scholar
• Tcheng J. E., Topol E. S., Kleinman N. S. Improvement in clinical outcome of coronary angioplasty by treatment with the GPIIb-llla inhibitor chimeric 7E3: multivariable analysis of the EPIC study. Circulation 1993; 88: 1–506
   Web of Science ®Google Scholar
• Thomas L., Chan P. W., Chang S., Damsky C. 5-Bromo-2-deoxyuridine regulates invasiveness and expression of integrins and matrix-degrading proteinases in a differentiated hamster melanoma cell. J. Cell Sci 1993; 105: 191–201
   PubMed Web of Science ®Google Scholar
• Wayner E. A., Orlando R. A., Cheresh D. A. Integrins αvβ3 and αvβ3 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J. Cell Biol 1991; 113: 919–929
   PubMed Web of Science ®Google Scholar
• Wicknam T. J., Mathias P., Cheresh D. A., Nemerow G. R. Integrins αvβ3 and αvβ3 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309–319
   PubMed Web of Science ®Google Scholar
• Yatohgo T., Izumi M., Kashiwagi H., Hayashi M. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct 1988; 13: 281–292
   PubMed Web of Science ®Google Scholar